Last reviewed · How we verify

Fentanyl Analgesic regimen

Ain Shams University · FDA-approved active Small molecule

Fentanyl Analgesic regimen is a Opioid analgesic Small molecule drug developed by Ain Shams University. It is currently FDA-approved for Moderate to severe acute pain, Chronic pain management, Perioperative analgesia. Also known as: Epidural Fentanyl Bupivacaine.

Fentanyl is a synthetic opioid agonist that binds to mu-opioid receptors in the central nervous system to produce analgesia and pain relief.

Fentanyl is a synthetic opioid agonist that binds to mu-opioid receptors in the central nervous system to produce analgesia and pain relief. Used for Moderate to severe acute pain, Chronic pain management, Perioperative analgesia.

At a glance

Generic nameFentanyl Analgesic regimen
Also known asEpidural Fentanyl Bupivacaine
SponsorAin Shams University
Drug classOpioid analgesic
TargetMu-opioid receptor (μ-OR)
ModalitySmall molecule
Therapeutic areaPain Management
PhaseFDA-approved

Mechanism of action

Fentanyl acts as a potent mu-opioid receptor agonist, activating inhibitory pathways in the spinal cord and brain that reduce pain signal transmission and perception. It is approximately 50-100 times more potent than morphine. The drug is commonly used in analgesic regimens for moderate to severe pain management, often in combination with other analgesics or as part of multimodal pain control strategies.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Fentanyl Analgesic regimen

What is Fentanyl Analgesic regimen?

Fentanyl Analgesic regimen is a Opioid analgesic drug developed by Ain Shams University, indicated for Moderate to severe acute pain, Chronic pain management, Perioperative analgesia.

How does Fentanyl Analgesic regimen work?

Fentanyl is a synthetic opioid agonist that binds to mu-opioid receptors in the central nervous system to produce analgesia and pain relief.

What is Fentanyl Analgesic regimen used for?

Fentanyl Analgesic regimen is indicated for Moderate to severe acute pain, Chronic pain management, Perioperative analgesia, Cancer pain.

Who makes Fentanyl Analgesic regimen?

Fentanyl Analgesic regimen is developed and marketed by Ain Shams University (see full Ain Shams University pipeline at /company/ain-shams-university).

Is Fentanyl Analgesic regimen also known as anything else?

Fentanyl Analgesic regimen is also known as Epidural Fentanyl Bupivacaine.

What drug class is Fentanyl Analgesic regimen in?

Fentanyl Analgesic regimen belongs to the Opioid analgesic class. See all Opioid analgesic drugs at /class/opioid-analgesic.

What development phase is Fentanyl Analgesic regimen in?

Fentanyl Analgesic regimen is FDA-approved (marketed).

What are the side effects of Fentanyl Analgesic regimen?

Common side effects of Fentanyl Analgesic regimen include Respiratory depression, Sedation, Nausea and vomiting, Constipation, Dizziness, Pruritus.

What does Fentanyl Analgesic regimen target?

Fentanyl Analgesic regimen targets Mu-opioid receptor (μ-OR) and is a Opioid analgesic.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing